Skip to main content

Table 1 Detailed The clinical characteristics of all 53 patients underwent EUS-guided hepaticogastrostomy

From: Outcomes and limitations of endoscopic ultrasound-guided hepaticogastrostomy in malignant biliary obstruction

Male gender, n (%) 38 (71.70%)
Age, mean [range] 74.66 [56–89]
Biliary obstruction cause, n (%)
 Pancreatic cancer 19 (35.8%)
 Cholangiocarcinoma 14 (26.4%)
 Gallbladder cancer 6 (11.3%)
 Hepatocellular carcinoma 3 (5.7%)
 Major duodenal papillary cancer 6 (11.3%)
 Duodenal cancer 1 (1.9%)
 Metastatic colorectal cancer 2 (3.8%)
 Metastatic breast cancer 1 (1.9%)
 Metastatic cancer of unknown origin 1 (1.9%)
Ascites, n (%) 11 (20.75%)
Liver metastases, n (%) 14 (26.42%)
Suppurative cholangitis, n (%) 21 (39.62%)
Reason for EUS-guided hepaticogastrostomy., n (%)
 Duodenal obstruction 25 (47.18%)
 Periampullary tumor infiltration 23 (43.39%)
 Failed biliary cannulation 5 (9.43%)